EDGAR Filing Documents for 0001493152-23-009222

Form 8-K - Current report:

SEC Accession No. 0001493152-23-009222

Filing Date

2023-03-28

Accepted

2023-03-28 09:46:57

Documents

Period of Report

2023-03-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	64140
2		ex1-1.htm	EX-1.1	115637
3		ex4-1.htm	EX-4.1	116047
4		ex4-2.htm	EX-4.2	120078
5		ex4-3.htm	EX-4.3	147564
6		ex5-1.htm	EX-5.1	19398
7		ex10-1.htm	EX-10.1	301725
8		ex99-1.htm	EX-99.1	15216
9		ex99-2.htm	EX-99.2	13289
10		ex5-1_001.jpg	GRAPHIC	2632
11		ex99-1_001.jpg	GRAPHIC	10626
12		ex99-2_001.jpg	GRAPHIC	8511
	Complete submission text file	0001493152-23-009222.txt		1306804

Data Files

Seq	Description	Document	Type	Size
13	XBRL SCHEMA FILE	invo-20230323.xsd	EX-101.SCH	3245
14	XBRL LABEL FILE	invo-20230323_lab.xml	EX-101.LAB	34916
15	XBRL PRESENTATION FILE	invo-20230323_pre.xml	EX-101.PRE	22801
17	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3643

Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240

Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505

INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)